References
- Antimisiaris S. G., Siablis D., Liatsikos E., Kalogeropoulou C., Tsota I., Tsotas V., Karnabatidis D., Fatouros D. G., Barbalias G. A. Liposome-coated metal stents: An in vitro evaluation of controlled-release modality in the ureter. J. Endourology 2000; 14: 743–747, [CSA]
- Kallinteri P., Antimisiaris S. G., Tsota I., Kalogeropoulou C., Karnabatidis D., Siablis D. Dexamethasone incorporating liposomes: An in vitro study of their applicability as a slow release delivery system of dexamethasone from covered metallic stents. Biomaterials 2002; 23: 4819–4826, [INFOTRIEVE], [CSA], [CROSSREF]
- Koromila G., Michanetzis G., Missirlis Y. F., Antimisiaris S. G. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemocompatibility. Biomaterials 2006; 2525–2533, [CSA], [CROSSREF]
- Magnani A., Busi E., Barbucci R. In-situ ATR-FTIR studies of protein adsorption on polymeric materials. Effectiveness of surface heparinization. J Mater Sci-Mater M 1994; 5: 839–843, [CSA], [CROSSREF]
- Schwartz R. S., Nicolas A., Chronos N. A., Virmani R. Preclinical restenosis models and drug-eluting stents: Still important, still much to learn. JACC 2004; 44: 1373–1385, [INFOTRIEVE], [CSA]
- Thomas A. C., Campbell J. H. Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis. Atherosclerosis 2004; 176: 73–81, [INFOTRIEVE], [CSA], [CROSSREF]